Brinza Crischentian, Popa Iolanda Valentina, Basarab Alexandru, Crisan-Dabija Radu, Burlacu Alexandru
Department of Interventional Cardiology, Cardiovascular Diseases Institute, 700503 Iasi, Romania.
Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T Popa", 700115 Iasi, Romania.
Healthcare (Basel). 2021 Aug 11;9(8):1033. doi: 10.3390/healthcare9081033.
(1) Background: Data suggest that patients with coronary chronic total occlusion (CTO) managed with percutaneous coronary intervention (PCI) could have better outcomes than those treated with optimal medical therapy alone. We aimed to systematically review dedicated scoring systems used to predict successful PCI in patients with CTO. (2) Methods: Electronic databases of MEDLINE (PubMed), Embase, and Cochrane were searched. (3) Results: 32 studies were included. We provided insights into all available predictive models of PCI success in CTO including predictive performance, validations, and comparisons between different scores and models' limitations. Considering the differences in the population included, coronary lesions, and techniques applied across clinical studies, the most used scores displayed a modest to good predictive value, as follows: J-CTO (AUC, 0.55-0.868), PROGRESS-CTO (AUC, 0.557-0.788), CL (AUC, 0.624-0.800), CASTLE (AUC, 0.633-0.68), and KCCT (AUC, 0.703-0.776). As PCI for CTO is one of the most complex interventions, using dedicated scoring systems could ensure an adequate case selection as well as preparation for an appropriate recanalization technique in order to increase chances of successful procedure. (4) Conclusion: Clinical models appear to be valuable tools for the prediction of PCI success in CTO patients. Clinicians should be aware of the limitations of each model and should be able to correctly select the most appropriate score according to real-life case particularities such as lesion complexity and operator experience in order to maximize success and achieve the best patients' outcomes.
(1) 背景:数据表明,接受经皮冠状动脉介入治疗(PCI)的冠状动脉慢性完全闭塞(CTO)患者可能比仅接受最佳药物治疗的患者有更好的预后。我们旨在系统评价用于预测CTO患者PCI成功的专用评分系统。(2) 方法:检索了MEDLINE(PubMed)、Embase和Cochrane的电子数据库。(3) 结果:纳入32项研究。我们深入探讨了所有可用的CTO患者PCI成功预测模型,包括预测性能、验证情况,以及不同评分之间的比较和模型的局限性。考虑到各临床研究中纳入人群、冠状动脉病变和应用技术的差异,最常用的评分显示出中等至良好的预测价值,如下:J-CTO(AUC,0.55 - 0.868)、PROGRESS-CTO(AUC,0.557 - 0.788)、CL(AUC,0.624 - 0.800)、CASTLE(AUC,0.633 - 0.68)和KCCT(AUC,0.703 - 0.776)。由于CTO的PCI是最复杂的介入治疗之一,使用专用评分系统可以确保进行充分的病例选择,并为适当的再通技术做好准备,以增加手术成功的机会。(4) 结论:临床模型似乎是预测CTO患者PCI成功的有价值工具。临床医生应了解每个模型的局限性,并应能够根据病变复杂性和术者经验等实际病例特点正确选择最合适的评分,以最大限度提高成功率并实现最佳患者预后。